Industry Ready To Oppose Possible FDA Action On Weight-Loss Petition
This article was originally published in The Tan Sheet
Executive Summary
FDA likely will not act soon on a controversial petition to consider weight-loss claims by dietary supplements as disease claims, industry stakeholders say